Introduction: Severe Sepsis and Drotrecogin Alfa (Activated)

Critical Care - United Kingdom
doi 10.1186/cc6180
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Drotrecogin Alfa (Activated) May Attenuate Severe Sepsis-Associated Encephalopathy in Clinical Septic Shock

Critical Care
Critical CareIntensive Care Medicine
2010English

Drotrecogin Alfa Activated as a Treatment for Severe Sepsis in Pediatric Cancer

Bone Marrow Transplantation
TransplantationHematology
2006English

Drotrecogin Alfa (Activated)

European Journal of Anaesthesiology
AnesthesiologyPain Medicine
2008English

The Safety Profile of Drotrecogin Alfa (Activated)

Critical Care
Critical CareIntensive Care Medicine
2007English

Drotrecogin Alfa in Patients With Severe Sepsis: Experience From a Tertiary Care Center in North India

Critical Care
Critical CareIntensive Care Medicine
2007English

Activated Protein C in Severe Sepsis

Intensive and Critical Care Nursing
Critical Care Nursing
2001English

Early Drotrecogin Alpha (Activated) Administration in Severe Sepsis Is Associated With Lower Mortality: A Retrospective Analysis of the Canadian ENHANCE Cohort

Critical Care
Critical CareIntensive Care Medicine
2009English

Nitric Oxide and Severe Sepsis

Archives of Disease in Childhood
Child HealthPediatricsPerinatology
1997English

Sepsis, Severe Sepsis and Septic Shock in Adults and Anaesthesia

Southern African Journal of Anaesthesia and Analgesia
AnesthesiologyPain Medicine
2002English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy